Business Description
Chongqing Zhifei Biological Products Co Ltd
NAICS : 325414
No.7 Jinyuan Road, Jiangbei District, 25th Floor, Chongqing, CHN, 400020
Compare
Compare
Traded in other countries / regions
300122.China
Description
Chongqing Zhifei Biological Products Co Ltd is a biotech company. It is a Chinese firm and engaged in the research and development, production, Distribution and import and export and sale of vaccines.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.82 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.18 | |||||
Interest Coverage | 364.61 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 12.05 | |||||
Beneish M-Score | -0.72 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 80.3 | |||||
3-Year EBITDA Growth Rate | 89.9 | |||||
3-Year EPS without NRI Growth Rate | 91.6 | |||||
3-Year FCF Growth Rate | 296.4 | |||||
3-Year Book Growth Rate | 61.6 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.05 | |||||
9-Day RSI | 43.82 | |||||
14-Day RSI | 44.77 | |||||
6-1 Month Momentum % | 13.55 | |||||
12-1 Month Momentum % | -32.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.25 | |||||
Quick Ratio | 1.67 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 110.71 | |||||
Days Sales Outstanding | 116.96 | |||||
Days Payable | 133.49 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.61 | |||||
Dividend Payout Ratio | 0.07 | |||||
3-Year Dividend Growth Rate | 56.7 | |||||
Forward Dividend Yield % | 0.61 | |||||
5-Year Yield-on-Cost % | 20.13 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.11 | |||||
Operating Margin % | 37.93 | |||||
Net Margin % | 31.47 | |||||
ROE % | 73.62 | |||||
ROA % | 43.2 | |||||
ROIC % | 81.67 | |||||
ROC (Joel Greenblatt) % | 109.29 | |||||
ROCE % | 84.51 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 13.84 | |||||
PE Ratio without NRI | 13.84 | |||||
Shiller PE Ratio | 71.77 | |||||
Price-to-Owner-Earnings | 14.92 | |||||
PEG Ratio | 0.1 | |||||
PS Ratio | 4.37 | |||||
PB Ratio | 7.91 | |||||
Price-to-Tangible-Book | 8.27 | |||||
Price-to-Free-Cash-Flow | 44.92 | |||||
Price-to-Operating-Cash-Flow | 29.22 | |||||
EV-to-EBIT | 11.83 | |||||
EV-to-EBITDA | 11.83 | |||||
EV-to-Revenue | 4.38 | |||||
EV-to-FCF | 46.36 | |||||
Price-to-Projected-FCF | 5.11 | |||||
Price-to-Median-PS-Value | 0.2 | |||||
Price-to-Graham-Number | 2.25 | |||||
Price-to-Net-Current-Asset-Value | 11.13 | |||||
Earnings Yield (Greenblatt) % | 8.44 | |||||
Forward Rate of Return (Yacktman) % | -15.75 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 35,566.965 | ||
EPS (TTM) (¥) | 6.996 | ||
Beta | 2.44 | ||
Volatility % | 58.15 | ||
14-Day RSI | 44.77 | ||
14-Day ATR (¥) | 4.261516 | ||
20-Day SMA (¥) | 103.5915 | ||
12-1 Month Momentum % | -32.33 | ||
52-Week Range (¥) | 82.36 - 188.58 | ||
Shares Outstanding (Mil) | 1,600 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chongqing Zhifei Biological Products Co Ltd Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |